ARCHIVES

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

This article is from The Cancer Letter archive.

Vol. 36 No. 04 | February 5, 2010

Download PDF Visit The Full Archive

Related Articles

Review Group Urges Increased Funding For NCI AIDS Drug Discovery Program

December 3, 1999

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

ONS Annual Meeting To Highlight Nursing Progress In ‘70s, ‘80s

April 20, 1990

Frozen Section Analysis Helps Avoid Second Surgery

September 30, 2005

In Brief: Esparza, Young, Busch, Rush Head Oncology Societies; Hipple Centers Honors Harry Eagle

June 2, 1989

CCOP Summary Statements Soon To Be Available

April 22, 1983